ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Pharmagreen Biotech Inc (PK)

Pharmagreen Biotech Inc (PK) (PHBI)

0.0017
0.00
(0.00%)
Closed January 11 4:00PM
Advanced chart

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0017
Bid
0.0015
Ask
0.0017
Volume
155,717
0.0015 Day's Range 0.0017
0.0006 52 Week Range 0.0047
Market Cap
Previous Close
0.0017
Open
0.0015
Last Trade
2000
@
0.0017
Last Trade Time
Financial Volume
$ 250
VWAP
0.001604
Average Volume (3m)
2,763,031
Shares Outstanding
663,645,739
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0
Revenue
3k
Net Profit
-569k

About Pharmagreen Biotech Inc (PK)

Pharmagreen Biotech Inc. (OTC Markets: PHBI) is developing its line of nutraceutical products, a proprietary blend of therapeutic plants and mushrooms. Pharmagreen's first new product, MaxGenomic(TM) Supplement, is a proprietary blend, formulated in the U. S. A., of nine medicinal mushrooms and six ... Pharmagreen Biotech Inc. (OTC Markets: PHBI) is developing its line of nutraceutical products, a proprietary blend of therapeutic plants and mushrooms. Pharmagreen's first new product, MaxGenomic(TM) Supplement, is a proprietary blend, formulated in the U. S. A., of nine medicinal mushrooms and six medicinal plants to help support the human mind and body. This supplement is produced in a U.S.A cGMP facility, in enteric capsules to enhance the bioavailability of the MaxGenomic(TM) supplement. Pharmagreen is also completing its research for its elixir, sublingual version, to provide immediate help and support to those who push their mental and physical capacity to their limits. Utilizing the Company's expertise in plant genetics, tissue culture, Pharmagreen's transgenic program uses the current technologies to research and create nutraceutical formulations as daily supplements, with the potential to improve lives and address a wide variety of aliments. Show more

Sector
Airports & Terminal Services
Industry
Airports & Terminal Services
Headquarters
Carson City, Nevada, USA
Founded
-
Pharmagreen Biotech Inc (PK) is listed in the Airports & Terminal Services sector of the OTCMarkets with ticker PHBI. The last closing price for Pharmagreen Biotech (PK) was $0. Over the last year, Pharmagreen Biotech (PK) shares have traded in a share price range of $ 0.0006 to $ 0.0047.

Pharmagreen Biotech (PK) currently has 663,645,739 shares outstanding. The market capitalization of Pharmagreen Biotech (PK) is $1.13 million. Pharmagreen Biotech (PK) has a price to earnings ratio (PE ratio) of 0.00.

PHBI Latest News

PHBI - Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company

  PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company   CARSON CITY, NV, Thursday, January 06, 2022 -- InvestorsHub NewsWire...

PHBI - Pharmagreen Previews Imminent Next Strategic Steps Advancing Its Proprietary Cannabis Tissue Culture Technology Into Recurring Revenue Generation

CARSON CITY, NV -- December 16, 2021 -- InvestorsHub NewsWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today continued in the release of a series of management updates from CEO Peter...

PHBI - Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard

CARSON CITY, NV -- Decembger 10, 2021 -- InvestorsHub NewsWire -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik. Today’s update...

PHBI - Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset

Carson City, NV -- December 2, 2021 -- InvestorsHub NewsWire -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first...

The Next Big Cannabis Innovation - Tissue Culture

December 1, 2021 -- InvestorsHub NewsWire -- via pennymillions --    Tissue culture itself is not new, but its new to the cannabis industry.  See a recent MJBizDaily...

PHBI Brings Tissue Culture To $6 B Cannabis Mrkt - Watch For PPS Breakout

November 11, 2021 -- InvestorsHub NewsWire -- via pennymillions -- Pharmagreen Biotech, Inc. (PHBI) continues to hover at its $0.027 200 Day Moving Average (MA) on the verge of a...

PHBI - Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry

CARSON CITY, NV -- November 11, 2021 -- InvestorsHub NewsWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that in advance of its entry into the multi-billion...

PHBI Volume Alert - Proprietary Tissue Culture Is Future Of Commercial Cannabis Industry

  November 9, 2021 -- InvestorsHub NewsWire -- via pennymillions -- Pharmagreen Biotech, Inc. (PHBI) trading volume has more than double since the original Breakout Alert earlier...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00016.250.00160.00190.001428790470.00179897CS
4-0.0001-5.555555555560.00180.00190.001218455660.00170207CS
12-0.0023-57.50.0040.0040.001227630310.00216362CS
260.000654.54545454550.00110.00470.000741005050.0025525CS
520.001142.8571428570.00070.00470.000629735360.00204457CS
156-0.0202-92.23744292240.02190.02190.00019528949390.00178821CS
260-0.7383-99.77027027030.740.8250.00019530787610.01467285CS

PHBI - Frequently Asked Questions (FAQ)

What is the current Pharmagreen Biotech (PK) share price?
The current share price of Pharmagreen Biotech (PK) is $ 0.0017
How many Pharmagreen Biotech (PK) shares are in issue?
Pharmagreen Biotech (PK) has 663,645,739 shares in issue
What is the market cap of Pharmagreen Biotech (PK)?
The market capitalisation of Pharmagreen Biotech (PK) is USD 1.13M
What is the 1 year trading range for Pharmagreen Biotech (PK) share price?
Pharmagreen Biotech (PK) has traded in the range of $ 0.0006 to $ 0.0047 during the past year
What is the reporting currency for Pharmagreen Biotech (PK)?
Pharmagreen Biotech (PK) reports financial results in USD
What is the latest annual turnover for Pharmagreen Biotech (PK)?
The latest annual turnover of Pharmagreen Biotech (PK) is USD 3k
What is the latest annual profit for Pharmagreen Biotech (PK)?
The latest annual profit of Pharmagreen Biotech (PK) is USD -569k
What is the registered address of Pharmagreen Biotech (PK)?
The registered address for Pharmagreen Biotech (PK) is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703 4934
What is the Pharmagreen Biotech (PK) website address?
The website address for Pharmagreen Biotech (PK) is www.pharmagreen.ca
Which industry sector does Pharmagreen Biotech (PK) operate in?
Pharmagreen Biotech (PK) operates in the AIRPORTS & TERMINAL SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
$ 0.00025
(-16.67%)
129.87M

PHBI Financials

Financials

PHBI Discussion

View Posts
Bluesky7 Bluesky7 2 weeks ago
Just curious, did you just graduate from a Laws of Attraction and Manifestation course at the Lotus Flower Academy in Butterfliesarefree, California or did you have a dream about fundamentals that just seemed so real?😏
👍️ 1
BIOCHEMUP BIOCHEMUP 2 weeks ago
Going to trips.
👍️0
Bluesky7 Bluesky7 1 month ago
'I’ve also been mindful of saving on health expenses. Canadian pharmacy has been a reliable option for affordable medications and supplements, which helps free up more budget for other things—like exploring stock opportunities'....lol hahaha! a clickbait epic fail. How weak and silly.


👍️0
Bluesky7 Bluesky7 1 month ago
How to Get a Cannabis License in Germany
There are three current companies contracted to produce cannabis for Germany. Those are Canadian firms Aphria and Aurora, and German company Demecan. They are allowed to produce three types of cannabis:

Type 1: 18% to 22% THC with less than 1% CBD
Type 2: 12% to 16% THC with less than 1% CBD
Type 3: 5% to 9% THC with 5% to 9% CBD

You may be surprised to learn that Germany does not issue actual cannabis cultivation licenses. Instead, they work through a system of contracts. The Cannabis Agency is a division of the BfArM department of Special Therapies and Traditional Medicines. Here is an overview of their contracting process:

BfArM holds a Europe-wide “public tendering process” (contract bidding)
BfArM issues “delivery contracts” for limited quantities and periods of time
The Cannabis Agency of BfArM purchases the cannabis, it cannot have excess amounts
The Cannabis Agency sells and distributes the cannabis; the Federal Opium Agency oversees cannabis importation
Until the next bidding opportunity, only the previously selected contractors can cultivate or manufacture cannabis
You need to meet many requirements to bid on German cannabis contracts. Below is a summary of what the German Cannabis Agency is looking for in contractors.

Cannabis Contract Bidding Requirements
Applicants cannot subcontract
Applicants must provide documentation to show that they are qualified to manufacture cannabis and that they have sufficient security
Applicants must have authorization to manufacture medicinal products under sec. 13 of the German Medicinal Products Act (AMG) and have a license for handling narcotic drugs
Applicants must be authorized to use the land where their site is located
The Cannabis Agency considers the applicant’s industry knowledge and professional experience, as evidenced by its suitability and contract requirements.
If approved, the applicant must follow requirements for safety measures (sec. 15 BtMG), record keeping (sec. 17 BtMG), and notifications to authorities (sec. 18 BtMG) in addition to GACP, EU-GMP, and specified monographs.
https://groweriq.ca/how-to-get-a-cannabis-license-in-germany/
👍️ 1
apontem apontem 1 month ago
Has anyone noticed the recent activity with Pharmagreen Biotech? The stock seems to be gaining attention lately—curious if anyone here has insights or is planning to invest. Speaking of investments, I’ve also been mindful of saving on health expenses. Canadian pharmacy has been a reliable option for affordable medications and supplements, which helps free up more budget for other things—like exploring stock opportunities
👍️ 2
Bluesky7 Bluesky7 2 months ago
Anybody here ever get an AGM notification or proxy materials?
https://stockhouse.com/companies/bullboard?symbol=phbi&threadid=36327794
👍️0
Bluesky7 Bluesky7 2 months ago
Very 'interesting' and thankfully some honest reporting about the lay of the land... looks like the same individual that wrote the script for that forgettable misleading video last month is also writing the press releases.... “While these revenue projections are grounded in extensive market research and current industry conditions" really?...somebody needs to get fired ASAP....just who is driving the PHBI bus anyway?? Caveat emptor. https://stockhouse.com/companies/bullboard?symbol=phbi&threadid=36316223
👍️ 1
BIOCHEMUP BIOCHEMUP 2 months ago
Slap 0.0029 and get us to $0.003+
👍️0
Bluesky7 Bluesky7 2 months ago
"The first step is to establish that something is possible; then probability will occur" Elon Musk

👍️ 1
TrendTrade2016 TrendTrade2016 2 months ago
OUCH...CLOWN
👍️0
Aceinhibitor561 Aceinhibitor561 2 months ago
Yes. Thinking of adding a bit more
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
Ready to push to $0.003ss
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
You stil in?
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
News sends PHBI $0.005+
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
Up 25%! Where is everyone?
👍️ 1
BIOCHEMUP BIOCHEMUP 2 months ago
I scooped up 0.0018sss. Finally, I'm in PHBI. 😁
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
Tanking.
👍️0
Aceinhibitor561 Aceinhibitor561 2 months ago
I Took the 333K .0021s, then it dropps to .0019 
👍️0
BIOCHEMUP BIOCHEMUP 2 months ago
What's happening here?
👍️0
Bluesky7 Bluesky7 3 months ago
Your 'old video' reply seems to be just disinfo-shade and now crickets. The video was posted on Youtube on October 8th, 2024 by
Zoggen360 Marketing and on X by a shareholder on October 16th. It is also not archived on the company's Youtube channel nor in the company website video section. In the video at the 2:50 mark it states that the CEO ‘has recently involved himself in on-line question and answer periods with investors…” with the first pne being October 7th . At the 2:23 mark the ceo’s ‘leadership is characterised ,,,,,,and a commitment to transparency’.
At the 2:28 mark ‘Pharmagreen has not only established itself as a leader in the cannabis industry…”. In what sector and by what metric(s)?
https://companiesmarketcap.com/eur/cannabis/largest-cannabis-companies-by-market-cap/
https://tracxn.com/d/trending-business-models/startups-in-cannabis-research-services/__bMKXdvu-83JlL7zrvYsJUPMAICFSyHckxwrpn66BKs8/companies
https://www.greenhousegrower.com/crops/cannabis/cannabis-top-20-north-americas-largest-commercial-grows/
https://biopharmguy.com/links/company-by-location-cannabis.php

At the 5:32 mark ‘For investors seeking a profitable company …Pharmagreen biotech inc deserves attention’. Since when did PHBI become a profitable company?
At the 5:51 mark the narrator states that 'as of the 2nd of October 2024 ...has a market cap of...and as of the same date it has 666xxxxxx shares outstanding…”
At the 6:26 mark ”….we trust you have enjoyed this informative video on Pharmagreen Biotech Inc traded on the OTCQB market’.


From the ‘ABOUT’ section at the PHBI website: “Pharmagreen Biotech Inc. (OTCQB: PHBI) is building a vertically…”
I rest my case.
👍️ 2
Bluesky7 Bluesky7 3 months ago
Who gave you that information?
👍️0
nycdream nycdream 3 months ago
That’s an old video
👍️0
Bluesky7 Bluesky7 3 months ago
As they say, 'the devil is in the details'. Why would management put out a commercial on youtube that states in the video title "PharmaGreen Biotec Inc. Infomercial (OTCQB:PHBI)", and in the intro-text: "PharmaGreen Biotech Inc. is an upcoming medicinal marijuana company based in California. The stock trades on the OTCQB under the symbol PHBI" and the same is stated in the video when obviously it does not trade on the QB? Also does anyone know if any of those images used in the video are truly actually representative of the operations/physical plant in California? If they are not, when added to the 'QB' misrepresentation (which is also stated on the company's X page) it is false and by base-line industry standards unacceptably misleading. How does that help?
👍️0
somberfox somberfox 3 months ago
Eh another pot stock. Garbage.
👍️ 1 🤣 1
Bluesky7 Bluesky7 3 months ago
How can something with no value (at present) be under valued? Unless you consider that worn out, tired, abused and misused element from the bottom of the pubic market periodic table called 'promotium' of value, The 'news' was just a rewrite regurgitation of the last podcast on X.
👍️0
rollingsandman rollingsandman 3 months ago
Today's volume 7.1M, above average
👍️0
Hercules1 Hercules1 3 months ago
Fairly solid accumulation today.
👍️0
The Night Stalker The Night Stalker 3 months ago
nice
👍️0
Hercules1 Hercules1 3 months ago
Volume exploding.

We are nearly 1/2 way to a penny.
👍️0
Hercules1 Hercules1 3 months ago
Added a few more.

Let’s ride.

Seeing copper here.
👍️0
ptk123 ptk123 3 months ago
I guess you forgot to read what it’s contingent on
👍️0
Hercules1 Hercules1 3 months ago
This is very seriously undervalued.

News out is excellent.

This can jump 500 percent from here in the very near term.
👍️ 1
rollingsandman rollingsandman 3 months ago
Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
09:15:00 AM ET, 10/10/2024 - GlobeNewswire

CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its latest project under development. During a special session on Creative Spaces, hosted on X on Monday, October 7, 2024, CEO Peter Wojcik shared exciting insights into the company's business advancements and growth strategies.

Pharmagreen is developing a specialized form of cannabis oil known as Live Rosin, a highly sought-after cannabis concentrate recognized for its unmatched purity, potency, and rich flavor profile. Produced through a solventless extraction process that uses no chemical solvents, Live Rosin sets a new standard for quality in the cannabis industry. Pharmagreen’s proprietary extraction technique ensures the highest cannabinoid recovery rates, while maintaining the plant’s natural properties. This process is further enhanced by the company’s exclusive Standard Organic Non-Spray Cultivation Procedures (SONSCP), ensuring the optimal cultivation and quality of their crops.

Pharmagreen’s innovative farming and processing model is designed to yield an average of 6,000 liters of Live Rosin per 100-acre farm, per crop cycle, depending on the cannabinoid content of the plants. With 4 to 5 crop cycles per year, depending on the strain, the company is poised for significant production output. Live Rosin currently commands retail prices ranging from $40 to $100 per gram in the U.S., with even higher prices in European markets.

Pharmagreen’s projected revenues are impressive:

At $1 per gram, estimated gross revenues are $19 million in year 1, rising to $32 million by year 3.
At $5 per gram, revenues are projected to reach $95 million in year 1 and $158 million by year 3.
At $10 per gram, revenues could soar to $190 million in year 1, growing to $317 million by year 3.
At $20 per gram, revenue estimates reach $381 million in year 1, and a staggering $635 million by year 3.

To ensure successful distribution and market access for its premium Live Rosin, Pharmagreen is actively seeking distributors, joint venture partnerships, and is exploring the acquisition of a cGMP-certified cannabis lab in Europe. This strategic move would enable Pharmagreen to tap into the lucrative EU cannabis market, where Live Rosin commands even higher prices.

While these revenue projections are grounded in extensive market research and current industry conditions, they are dependent on the successful completion of several key milestones. These include securing cannabis production and processing licenses, export/import permits from foreign governments, land leases, and the necessary funding to establish the cannabis farm and processing facility, as well as ensuring market access for product sales. Pharmagreen is making consistent progress toward these critical objectives, though outcomes cannot be guaranteed at this stage.

Peter Wojcik, CEO of Pharmagreen Biotech Inc., stated, "The revenue projections are indeed promising, and I am eager to bring them to fruition once the initial milestones are achieved. This is an exciting project, and it’s a privilege to be leading its development."
🗑️ 1 🚮 1
Bluesky7 Bluesky7 3 months ago
If anyone here has level 2 market access, (I don't and don't need/want a subscription). I am wondering if 'you' wouldn't mind posting the individual trades of PHBI shares from September 10th to the close of the market on September 19th, or a page link to same, and hopefully that would include the name or number of the B/D buyers and sellers. Doing some basic DD. Any assistance is greatly appreciated, Thanks
👍️0
ptk123 ptk123 3 months ago
What news are they talking about?
👍️0
rollingsandman rollingsandman 3 months ago
News perhaps

@pharmagreeninc
Pharmagreen Biotech Inc. (OTC PINK: $PHBI) is pleased to announce that it will be releasing its news release this week, as previously communicated. Pharmagreen remains committed to transparency and keeping stakeholders informed as it continues to advance business development.
6:45 AM · Oct 9, 2024
·
3,145
Views
👍️0
rollingsandman rollingsandman 3 months ago
is there actual news, or is this hype?
👍️0
rbl100 rbl100 3 months ago
You ever get your money back from BHUB? I am still waiting.
👍️0
BIOCHEMUP BIOCHEMUP 3 months ago
This board is quiet.
👍️0
BIOCHEMUP BIOCHEMUP 3 months ago
Holding its gains pretty good.
👍️ 1
bell345 bell345 3 months ago
I see some people excited about this on Twitter or X, do they have any money? do they have any financials? from what I can find is they pretty much have nothing but that's from like a year ago
👍️0
10thMountain 10thMountain 3 months ago
Nice close here
👍️ 1
TradeSmart.ai TradeSmart.ai 3 months ago
Looking good $PHBI
👍️ 1
The Night Stalker The Night Stalker 3 months ago
on sale
👍️0
Fairgrounds Fairgrounds 3 months ago
Bought a few here
👍️ 1
The Night Stalker The Night Stalker 3 months ago
wild
👍️0
The Night Stalker The Night Stalker 3 months ago
churn
👍️ 2
BERKSHIRE AGENT BERKSHIRE AGENT 3 months ago
Nice close!
👍️ 1
INV4 INV4 3 months ago
0.0046 (+15%) Nice! 😃

$PHBI
👍️0
BERKSHIRE AGENT BERKSHIRE AGENT 4 months ago
Nice day here. Stoked for coming weeks ;)
👍️ 1

Your Recent History

Delayed Upgrade Clock